FDA Inspection 1058718 — Tower Health IRB
The FDA completed an inspection of Tower Health IRB on June 28, 2018 in West Reading, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 28, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- West Reading, PA (United States)
Additional Details
IRB